Increased Blood Concentration of IgG Degradation Products in Prostate Cancer
- 5 Downloads
For elucidation of the mechanisms of IgG binding with human plasminogen in prostate cancer patients, we propose an original ELISA on polystyrene plates with immobilized heavy and light plasminogen chains. The level of IgG bound to plasminogen heavy chain in the serum of prostate cancer patients significantly exceeded that in healthy volunteers. IgG treated with plasmin more actively (by more than 2 times) bound plasminogen heavy chain than intact IgG. These findings indicate the involvement of lysine-binding sites of plasminogen heavy chain in the interaction with the C-terminal lysine of IgG and their fragments. ROC analysis of ELISA data showed significant differences between serum samples from patients with prostate cancer and benign prostatic hyperplasia. It is hypothesized that IgG in the tumor region undergo proteolysis and their products appear in the circulation.
Key Wordsplasminogen immunoglobulin G prostate cancer benign prostatic hyperplasia enzyme immunoassay
Unable to display preview. Download preview PDF.
- 2.Anichkov NM, Kvetnoi IM, Konovalov SS. Biology of Tumor Growth. Moscow, 2004. Russian.Google Scholar
- 3.Goufman EI, Moshkovskii SA, Tikhonova OV, Lokhov PG, Zgoda VG, Serebryakova MV, Toropygin IYu, Vlasova MA, Archakov AI, Safarova MR, Makarov OV. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions. Biochemistry (Moscow). 2006;71(4):354-360.Google Scholar
- 11.Harpel PC, Sullivan R, Chang TS. Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived Fab as the plasminogen-binding fragment. J. Biol. Chem. 1989;264(1):616-624.Google Scholar
- 12.The cancer degradome. Proteases and Cancer Biology. Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF, eds. New York, 2008.Google Scholar